ERBB2 and gastric cancer: This study demonstrates that the level of PGK1 protein is directly correlated with the sensitivity of HER2-dependent gastric cancer cells to lapatinib, providing a potential strategy for the application of lapatinib in patients with gastric cancer who have high HER2 expression.